Published in
Taylor and Francis Group, Journal of Medical Economics (JME), 1(25), p. 309-320, 2022
DOI: 10.1080/13696998.2022.2042106
Links
Tools
Cost-effectiveness of andexanet alfa versus four-factor prothrombin complex concentrate for the treatment of oral factor Xa inhibitor-related intracranial hemorrhage in the US
Journal article published in 2022 by
John Fanikos 
,
Joshua N. Goldstein ,
Belinda Lovelace ,
Anne C. Beaubrun ,
Robert S. Blissett ,
Filipa Aragão
,
Joshua N. Goldstein ,
Belinda Lovelace ,
Anne C. Beaubrun ,
Robert S. Blissett ,
Filipa Aragão
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 